Saturday, October 25, 2014 5:58:51 AM
Now, that does not mean that MANF will be denied orphan status, it just means that JN did not think that AMBS warranted inclusion in his article on orphan status, and he is one of the biggest AMBS backers.
Now, biotechs are BEST when anticipating news, and so while the orphan status indication is not going to come tomorrow, an anticipation by the market that it will come is great for those who want to be in the stock.
Regardless of the presence of that graph showing increased chances for eventual approval, I have more reservations that MANF will ever get to the clinic.
Some will say that means I am against MANF. That is not true, you never know until you test, and they will be testing MANF. Right now, that is where the value lies.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM